These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2180020)

  • 21. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP; Karlberg BE
    Scand J Urol Nephrol Suppl; 1984; 79():93-7. PubMed ID: 6089325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
    Gasowski J; Wilkins A; Drzewoski J; Kłoś J; Gaciong Z; Kabat M; Grodzicki T
    Cardiol J; 2010; 17(3):259-66. PubMed ID: 20535716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
    Pieniazek W; Franczuk P; Janicki K
    Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia.
    Middeke M; Krone W
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):629-31. PubMed ID: 7516014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of perindopril on structural and functional changes in hypertensive arteries.
    Thomas JR; Asmar RG; Safar ME
    S Afr Med J; 1991 Oct; Suppl():6-9. PubMed ID: 1925815
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.
    Williams A; Kenny D; Wilson D; Fagenello G; Nelson M; Dunstan F; Cockcroft J; Stuart G; Fraser AG
    Eur J Clin Invest; 2012 Aug; 42(8):891-9. PubMed ID: 22471392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new ACE inhibitor and two new angiotensin receptor blockers for hypertension.
    Med Lett Drugs Ther; 1999 Nov; 41(1065):105-6. PubMed ID: 10575416
    [No Abstract]   [Full Text] [Related]  

  • 32. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of perindopril on hypertension, serum angiotensin-I-converting enzyme activity and urine level of N-acetyl-beta-D-glucosaminidase].
    Wang Z; Li Y; Zhou Y
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):233-6. PubMed ID: 9868122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group.
    Overlack A; Adamczak M; Bachmann W; Bönner G; Bretzel RG; Derichs R; Krone W; Lederle RM; Reimann HJ; Zschiedrich H
    Am J Med; 1994 Aug; 97(2):126-34. PubMed ID: 8059778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria in diabetic patients.
    Doyle A
    Nurs Times; 1991 Jul 10-16; 87(28):43. PubMed ID: 1852640
    [No Abstract]   [Full Text] [Related]  

  • 38. [The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
    Kirichenko AA; Ebzeeva EIu
    Kardiologiia; 2002; 42(10):36-40. PubMed ID: 12494055
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent antihypertensive efficacy and tolerability of perindopril in a large, observational, 12-week, general practice-based study.
    Tsoukas G; Anand S; Yang K;
    Am J Cardiovasc Drugs; 2011; 11(1):45-55. PubMed ID: 21265582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.